GABRIELLE DU SABLON: Open Payments
NPI 1750804662 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 55 payments from 18 companies in 2025. Trend: 2023 $2,607 · 2024 $2,838 · 2025 $1,683
Food & beverage: $1,683
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 17 | $386 |
| Novo Nordisk Inc | 10 | $261 |
| CeQur Corporation | 1 | $247 |
| Ascendis Pharma Endocrinology Inc | 3 | $156 |
| Corcept Therapeutics | 6 | $145 |
| Lilly USA, LLC | 2 | $97 |
| Amgen Inc. | 4 | $88 |
| BETA BIONICS, INC. | 1 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Tandem Diabetes Care, Inc. | 1 | $30 |
Products named: FREESTYLE LIBRE 3, CeQur Simplicity, Ozempic, Yorvipath, Korlym, MOUNJARO, TEPEZZA, iLet Bionic Pancreas.
Industry payments across FL — which companies pay providers there.
